HIV/AIDS - Aug 9, 2017 Edition

Can't see this email? View it online

	August 9, 2017
	HIV/AIDS
	The latest HIV/AIDS news from News Medical

	HIV prevention drug to be trialed by Britain's NHS After a High Court case, an HIV prevention drug is soon to be available on the NHS. NHS England has issued a statement saying that pre-exposure prophylaxis (PrEP) treatment for HIV shall be available to an initial 10,000 people for a trial period of three years.

	HIV prevention and treatment being overlooked in older populations When it comes to HIV prevention and treatment, there is a growing population that is being overlooked -- older adults -- and implicit ageism is partially responsible for this neglect, according to a presentation at the 125th Annual Convention of the American Psychological Association.

			UM SOM researchers to study adaptive immune responses of infants with HIV exposure in utero The University of Maryland School of Medicine's Institute for Global Health and the Institute of Human Virology have been awarded a $2 million five-year grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study the impact exposure to HIV has on the immune systems of infants in utero and how those changes impact the ability of infants to fight off infections after birth.

			TMDU-led researchers identify protein critical to early stages of cellular HIV infection When a virus enters a cell, one of the first steps in the process of infecting that cell is removal of the protein coat that surrounds the virus's genetic material.

			Latency reversing agent makes dormant HIV-infected cells vulnerable to clearance The ability for HIV to hide in the body in a dormant state makes curing the 40 million people living with the virus a challenge. Researchers at the University of North Carolina at Chapel Hill have shown the drug Vorinostat reverses this latency, causing resting CD4 T-cells to express HIV.

	Congress revamps housing program to benefit areas where HIV is spreading In a bipartisan push, Congress has restructured a federal program that provides housing assistance for people living with HIV to funnel more money into areas struggling to control the outbreak.

	Researchers receive $3.8 million NIH grant to study medical marijuana's impact on opioid use for pain The National Institutes of Health has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $3.8 million grant for the first long-term study to test whether medical marijuana reduces opioid use among adults with chronic pain, including those with HIV.

	Injectable ART may have same effectiveness as standard oral treatments Antiretroviral therapy (ART) intramuscularly administered may have the same effectiveness as current oral treatments.

	Oral Candidiasis (Oral Thrush) Oral candidiasis, commonly known as oral thrush, is a fungal infection that occurs inside the mouth. It is not contagious and in most cases can be treated with a simple course of topical antifungal medication applied directly to the affected area in the mouth.

	What is Molluscum Contagiosum? Molluscum contagiosum represents a superficial viral infection of the skin that is most commonly seen in children and young adults. Caused by the Molluscum contagiosum virus, this disease typically presents as smooth, small, flesh-colored and dome-shaped protrusions on the skin with a central indentation (umbilication).

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Update your Newsletter Subscriptions